Yahoo Web Search

  1. Ad

    related to: mark iv

Search results

    • Small Business - Cordele Dispatch | Cordele Dispatch

      Cordele Dispatch· 27 minutes ago

      GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024